• Explore /
  • Poster
  • / Intrapatient comparative efficacy of selective RET inhibitors using growth modulation index in patients with RET aberrant cancers.

Intrapatient comparative efficacy of selective RET inhibitors using growth modulation index in patients with RET aberrant cancers.

Abstract Poster

Authors

Mohamed Gouda

Mohamed Alaa Gouda

The University of Texas MD Anderson Cancer Center, Houston, TX

Mohamed Alaa Gouda , Jibran Ahmed , Blessie Elizabeth Nelson , Mirella Nardo , Jason Roszik , Maria E. Cabanillas , Mimi I-Nan Hu , Naifa Lamki Busaidy , Steven I. Sherman , Ramona Dadu , Aung Naing , Daniel D. Karp , Jordi Rodon Ahnert , David S. Hong , Yasir Y Elamin , George R. Blumenschein , John Heymach , Funda Meric-Bernstam , Vivek Subbiah

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology

Track

Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology

Sub Track

New Targets and New Technologies (non-IO)

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 3086)

DOI

10.1200/JCO.2023.41.16_suppl.3086

Abstract #

3086

Poster Bd #

284

Abstract Disclosures

Similar Posters

First Author: Aaron Scott Mansfield

First Author: Lori J. Wirth

First Author: Matthew H. Taylor

First Author: Takeshi Terashima